Electronic cigarette aerosol induces significantly less cytotoxicity than Tobacco smoke

Toxicology Mechanisms and Methods

Volumn 26, Issue 6, 2016, Pages 477-491

  Azzopardi, David ^a   Patel, Kharishmatel ^a   Jaunky, Tomasz ^a   Santopietro, Simone ^a   Camacho, Oscar M ^a   McAughey, John ^a   Gaça, Marianna ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Air liquid interface; e cigarettes; Lung epithelial cells; Tobacco smoke

Indexed keywords

CIGARETTE SMOKE; NICOTINE; TOBACCO SMOKE; AEROSOL; SMOKE;

AEROSOL; ARTICLE; CELL VIABILITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DILUTION; DOSIMETRY; EC50; ELECTRONIC CIGARETTE; HUMAN; HUMAN CELL; IN VITRO STUDY; PARTICULATE MATTER; PRIORITY JOURNAL; QUARTZ CRYSTAL MICROBALANCE; UPTAKE ASSAY; ADVERSE EFFECTS; BRONCHUS; CELL CULTURE TECHNIQUE; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; EPITHELIUM CELL; PATHOLOGY; PROCEDURES; SMOKE; TOBACCO; TOXICITY; TOXICITY TESTING;

AEROSOLS; BRONCHI; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; EPITHELIAL CELLS; HUMANS; NICOTINE; SMOKE; TOBACCO; TOXICITY TESTS;

EID: 85006784479     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376516.2016.1217112     Document Type: Article

References (99)

1. Adamson J, Azzopardi D, Errington G, et al. Assessment of an in vitro whole cigarette smokxposure system: the Borgwaldt RM20S 8-syringe smoking machine. Chem Cent J. 2011;5:50-60.
2. Adamson J, Hughes S, Azzopardi D, et al. Real-time assessment of cigarette smoke particleposition in vitro. Chem Cent J. 2012;6:98.
3. Adamson J, Thorne D, Errington G, et al. An inter-machine comparison of tobacco smoke particleposition in vitro from six independent smokxposure systems. Toxicol In Vitro. 2014;28:1320-8.
4. Adamson J, Thorne D, McAughey J, et al. Quantification of cigarette smoke particleposition in vitro using a triplicate quartz crystal microbalancxposure chamber. Biomed Res Int. 2013;2013:685074.
5. Armitage AK, Dixon M, Frost BE, et al. Thffect of inhalation volume and breath-hold duration on the retention of nicotine and solanesol in the human respiratory tract and on subsequent plasma nicotine concentrations during cigarette smoking. Beitr Tabakforsch Int. 2004;4:240-9.
6. Azzopardi D, Haswell LE, Foss-Smith G, et al. Evaluation of an air-liquid interface cell culture model for studies on the inflammatory and cytotoxic responses to tobacco smoke aerosols. Toxicol In Vitro. 2015;29:1720-8.
7. Baker RR, Lewis LS. A review of the incidence and consequences of cigarette filter venlocking among smokers. Beitr Tabakforsch Int. 2001;4:209-28.
8. Behar RZ, Davis B, Wang Y, et al. Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro. 2014;28:198-208.
9. Behar RZ, Hu Talbo. Puffing topography and nicotine intake olectronic cigarettsers. PLoS One. 2015;10:e0117222.
10. Bernstein DM. A review of the influence of particle size, puff volume, and inhalation pattern on theposition of cigarette smoke particles in the respiratory tract. Inhal Toxicol. 2004;16:675-89.
11. Bombick DW, Bombick BR, Ayres PH, et al. Evaluation of the genotoxic and cytotoxic potential of mainstream whole smoke and smoke condensate from a cigarette containing a novel carbon filter. Fundam Appl Toxicol. 1997;39:11-7.
12. Breheny D, Cunningham F, Kilford J, et al. Application of a modified gaseous exposure system to the in vitro toxicological assessment of tobacco smoke toxicants. Environ Moutagen. 2014;55:662-72.
13. Borgwaldt, Smoking Machine RM20S. Available from: http://borgwaldt.hauni.com/en/instruments/smoking-machines/rotary/smoking-machine-rm20s.html[last accessed 1 June 2016].
14. Brunnemann KD, Yu L, Hoffmann D. Assessment of carcinogenic volatile n-nitrosamines in tobacco and in mainstream and sidestream smoke from cigarettes. Cancer Res. 1977;37:3218-22.
15. Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotinelivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotinelivery: randomised cross-over trial. Tob Control. 2010;19:98-103.
16. Burns DM, Dybing E, Gray N, et al. Mandated lowering of toxicants in cigarette smoke: escription of the World Health Organization TobReg proposal. Tob Control. 2008;17:132-41.
17. Caldwell B, Sumner W, Crane J. A systematic review of nicotiny inhalation: is there a role for the inhaled route? Nicotine Tob Res. 2012;14:1127-39.
18. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23:236-40.
19. Chen IL. FDA summary of adversvents on electronic cigarettes. Nicotine Tob Res. 2013;15:615-6.
20. Cheng T. Chemicavaluation olectronic cigarettes. Tob Control. 2014;23:211-17.
21. Colard S, Verron T, Julien R, et al. Relationship between cigarette yields and smoking timndeifferent machine smoking regimes. Beitr Tabakforsch Int. 2014;26:4-18.
22. CORESTA 2015oo https://www.coresta.org/sites/default/files/technical_documents/main/CRM_81.pdf
23. Côté F, Létourneau C, Mullard G, Voisine R. Estimation of nicotine and tar yields from human-smoked cigarettes before and after the implementation of the cigarette ignition propensity regulations in Canada. Reg Tox Pharm. 2011;61:S51-S9.
24. Dautzenberg B, Bricard D. Real-time characterization o-cigarettes use: the 1 million puffs study. J Addict Res Ther. 2015;6:2.
25. Digard H, Proctor C, Kulasekaran A, et al. Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine Tob Res. 2013;15:255-61.
26. Eldridge A, Betson TR, Vinicius Gam, McAdam K. Variation in tobacco and mainstream smoke toxicant yields from selected commercial cigarette products. Regul Toxicoharmacol. 2015;71:409-27.
27. European Commission. 2015. 2015. http://ec.europa.eu/public_opinion/archives/ebs/ebs_429_en.pdf
28. European Commission. 2014. http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf
29. Fagerström KO, Schildt EB. Should the European Union lift than on snus? Evidence from the Swedish experience. Addiction. 2003;98:1191-5.
30. Farsalinos KE, Romagna G, Tsiapras D, et al. Evaluation olectronic cigarettse (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities’ regulation. Int J Environ Res Public Health. 2013;10:2500-14.
31. Farsalinos KE, Spyrou A, Tsimopoulou K, et al. Nicotine absorption from electronic cigarettse: comparison between first and new-generation devices. Sci Rep. 2014;4:4133.
32. Farsalinos KE, Voudris V, Poulas K. E-cigarettes generate high levels of aldehydes only in ’dry puff’ conditions. Addiction. 2015;110:1352-6.
33. Flick DA, Gonzalez-Rothi RJ, Ocie Harris J, Gifford GE. Rat lung macrophage tumor cytotoxin production: impairmeny chronic in vivo cigarette smokxposure. Cancer Res. 1985;45:5225-9.
34. Food and Drug Administration (FDA) 2012. http://www.fda.gov/downloads/TobaccoProducts/Labeling/RulesRegulationsGuidance/UCM297981.pdf
35. Food and Drug Administration (FDA) 2013. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/ucm348930.pdf
36. Food and Drug Administration (FDA) 2016. https://www.gpo.gov/fdsys/pkg/FR-2016-05-10/pdf/2016-10685.pdf
37. Forste, Liu C, Duk G, et al. An experimental method to study emissions from heated tobacco between 100-200 °C. Chem Cent J. 2015;9:20.
38. Garcia-Canton C, Errington G, Anadon A, Meredith C. Characterisation of an aerosoxposure system to evaluate the genotoxicity of whole mainstream cigarette smoksing the in vitro γH2AX assay by high content screening. BMharmacol Toxicol. 2014;15:41.
39. Gminski R, Tang T, Mersch-Sundermann V. Cytotoxicity and genotoxicity in human lung epithelial A549 cells caused by airborne volatile organic compounds emitted from pine wood and oriented strand boards. Toxicol Lett. 2010;196:33-41.
40. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133-9.
41. Goniewicz ML, Lingas EO, Hajek P. Patterns olectronic cigarettse and useeliefs about their safety and benefits: an internet survey. Drug Alcohol Rev. 2013;32:133-40.
42. Hajek P, Goniewicz ML, Phillips A, et al. Nicotine intake from electronic cigarettes on initiase and after 4 weeks of regulase. Nicotine Tob Res. 2015;17:175-9.
43. Health Canada. 1999. http://www.qp.gov.bc.ca/stat_reg/regs/health/oic_94.pdf
44. Health Canada. Official method T-503 - in vitro micronucleus assay for mainstream tobacco smoke.Ottawa, QC: Health Canada; 2004.
45. Hiscock R, Goniewicz ML, McEwen A, et al. E-cigarettes: online survey of UK smoking cessation practitioners. Tob Induc Dis. 2014;12:13.
46. Hoffmann D, Wynder EL. The reduction of the tumorigenicity of cigarette smoke condensaty addition of sodium nitrate to tobacco. Cancer Res. 1967;27:172-4.
47. International Commission on Radiologicarotection (ICPR). ICRP publication 66: human respiratory tract model for radiological protection; Elsevier health sciences. Ann ICRP. 1994;24:1-3.
48. Ishikawa S, Suzuki T, Nagata Y. Analysis of cigarette smokeposition within an in vitro exposure system for simulating exposure in the human respiratory tract. Beitr Tabakforsch Int. 2016;27:20-9.
49. Iskandar AR, Martin F, Talikk, et al. Systems approaches evaluating the perturbation of xenobiotic metabolism in response to cigarette smokxposure in nasal and bronchial tissues. BioMed Res Int. 2013;2013:512086.
50. ISO. 1999. http://www.iso.org/iso/catalogue_detail.htm?csnumber=28324
51. ISO. 2000. http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=28323
52. ISO. 2012. http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=60404
53. Jackson KJ, Schroede J, Hoffman AC. Mouth levexposure and similarity to machine-smoked constituent yields. Tob Regul Sci. 2016;2:3-8.
54. Jin M, Earla R, Shah A, et al. A LC-MS/MS method for concurrenetermination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers. J Neuroimmunharmacol. 2012;7:289-99.
55. Kaur N, Lacass, Roya J-P, et al. Evaluation of precision and accuracy of the Borgwaldt RM20S(®)smoking machinesigned for in vitro exposure. Inhal Toxicol. 2010;22:1174-83.
56. Medicines and Healthcare products Regulatory Agency (MHRA). Nicotine replacement therapy and harm reduction. Drug Safety Update. 2010;3:6. https://www.gov.uk/drug-safety-update/nicotine-replacement-therapy-and-harm-reduction
57. Majeed S, Frentzel S, Wagner S, et al. Characterization of the Vitrocell® 24/48 in vitro aerosoxposure system using mainstream cigarette smoke. Chem Cent J. 2014;8:62.
58. Manigrasso M, Buonanno G, Stabile L, et al. Particloses in the pulmonary lobes olectronic and conventional cigarettsers. Environ Pollut. 2015;202:24-31.
59. Margham J, McAdam K, Forste, et al. Chemical composition of an e-cigarette aerosol? a quantitative comparison with cigarette smoke. Chem Res Toxicol. 2016 doi: 10.1021/acs.chemrestox.6b00188.
60. Mariner DC, Ashley M, Shepperd CJ, et al. Mouth level smokxposursing analysis of filters from smoked cigarettes: a study oight countries. Regul Toxicoharmacol. 2011;61:S39-S50.
61. Misr, Leverette RD, Cooper BT, et al. Comparative in vitro toxicity profile olectronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int J Environ Res Public Health. 2014;11:11325-47.
62. Neilson L, Mankus C, Thorne D, et al. Development of an in vitro cytotoxicity model for aerosoxposursing 3D reconstructed human airway tissue; application for assessment o-cigarette aerosol. Toxicol In Vitro. 2015;29:1952-62.
63. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine-containing products using thCDA approach. Eur Addict Res. 2014;20:218-25.
64. Onoue S, Yamamoto N, Seto Y, Yamada S. Pharmacokinetic study of nicotine and its metabolite cotinine to clarify possible association between smoking and voiding dysfunction in rats using UPLC/ESI-MS. Drug Metab Pharmacokinet. 2011;26:416-22.
65. Palipudi KM, Mbulo L, GATS Collaborative Group. et al. Awareness and currense olectronic cigarettes in Indonesia, Malaysia, Qatar, and Greece: findings from 2011-2013 global adult tobacco surveys. Nicotine Tob Res. 2016;18:501-7.
66. Paur H-R, Cassee FR, Teeguarden J, et al. In vitro celxposure studies for the assessment of nanoparticle toxicity in the lung—ialog between aerosol science and biology. J Aerosol Sci. 2011;42:668-92.
67. Pepper J, Brewer N. Electronic nicotinelivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control. 2014;23:375-84.
68. Phillips J, Kluss B, Richter A, Massey ED. Exposure oronchiapithelial cells to whole cigarette smoke: assessment of cellular responses. Altern lab Anim. 2005;33:239-48.
69. Pichelstorfer L, Hofmann W, Winkler-Heil R, et al. Simulation of aerosoynamics and deposition of combustible and electronic cigarette aerosols in the human respiratory tract. J Aerosol Sci. 2016;99:125-32.
70. Polosa R, Caruso M, Guarino F. Comments on Schefflet al. cytotoxivaluation o-liquid aerososing different lung derived cell models. Int J Environ Res Public Health. 2016;13:108.
71. Public Health England. 2015. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/457102/Ecigarettes_an_evidence:update_A_report_commissioned_by_Public_Health_England_FINAL.pdf
72. Purkis SW, Troude V, Hill CA. Effect of puffing intensity on cigarette smoke yields. Regul Toxicoharmacol. 2013;66:72-82.
73. Rickert WS, Trivedi AH, Momin RA, et al. Effect of smoking conditions and methods of collection on the mutagenicity and cytotoxicity of cigarette mainstream smoke. Toxicol Sci. 2007;96:285-93.
74. Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. 2nd ed. Boca Raton, (FL): CRress; 2013.
75. Rodu B, Godshall WT. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct J. 2006;3:37.
76. Romagna G, Allifranchini E, Bocchietto E, et al. Cytotoxicity evaluation olectronic cigarette vapoxtract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smokxtract. Inhal Toxicol. 2013;25:354-61.
77. Royal College ohysicians. 2016. https://www.rcplondon.ac.uk/sites/default/files/media/Documents/Nicotine%20without%20smoke_0.pdf?token=uV0R0Twz
78. Sahu SK, Tiwar D, Bhangare RC, Pandit GG. Particle sizistribution of mainstream and exhaled cigarette smoke and predictiveposition in human respiratory tract. Aerosol Air Qual Res. 2013;13:324-32.
79. Sangani RG, Ghio AJ. Lung injury after cigarette smoking is particle related. Int J Chron Obstruculmon Dis. 2011;6:191-8.
80. Scheffler S, Dieken H, Krischenowski O, Aufderheid. Cytotoxivaluation o-liquid aerososing different lung-derived cell models. Int J Environ Res Public Health. 2015;12:12466-74.
81. Scheffler S, Dieken H, Krischenowski O, Aufderheid. Response to Polost al. Comments on Schefflet al. Cytotoxic Evaluation of E-Liquid Aerosol Using Different Lung Derived Celodels. Int. J. Environ. Res. Public Health, 2015, 12, 12466-12474. Int J Environ Res Public Health. 2016;13:109. doi: 10.3390/ijerph13010109.
82. Schmid A, Baumlin N, Ivonne D, et al. Roflumilast partially reverses smoke-induced mucociliary dysfunction. Respir Res. 2015;16:135.
83. Schoenborn CA, Gindi RM. 2015. http://www.cdc.gov/nchs/data/databriefs/db217.pdf
84. Schroede J, Hoffman AC. Electronic cigarettes and nicotine clinical pharmacology. Tob Control. 2014;23:230-5.
85. Schweitzer K, Chen S, Law S, et al. Endotheliaisruptive proinflammatory effects of nicotine and e-cigarette vapoxposures. Am J Physiology Lung Celohysiol. 2015;309:175-87.
86. Sosnowski TR, Kramek-Romanowska K. Predicted deposition o-cigarette aerosol in the human lungs. J Aerosoed Pulm Drug Deliv. 2016;29:299-309.
87. St Helen G, Havel C, Dempsey DA, et al. Nicotinelivery, retention and pharmacokinetics from various electronic cigarettes. Addiction. 2016;111:535-44.
88. Thorne D, Adamson J. A review of in vitro cigarette smokxposure systems. Exp Toxicoathol. 2013;65:1183-93.
89. Thorne D, Dalrymple A, Dillon D, et al. A comparative assessment of cigarette smoke aerosols using an in vitro air-liquid interface cytotoxicity test. Inhal Toxicol. 2015;27:629-40.
90. Thorne D, Wilson J, Kumaravel TS, et al. Measurement of oxidative DNA damage induced by mainstream cigarette smoke in cultured NCI-H292 human pulmonary carcinoma cells. Mutat Res. 2009;673:3-8.
91. University of Kentucky: 3R4F reference cigarette. Available from: https://ctrp.uky.edu/resources/pdf/webdocs/3R4F%20Preliminary%20Analysis.pdf [last accessed 1 June 2016].
92. Unwalla H, Ivonne, Dennis JS, et al. Transforming growth factor-b1 and cigarette smoke inhibit the ability o2-agonists to enhancpithelial permeability. Am J Respir Celol Biol. 2015;52:65-74.
93. US Department of Health and Human Services. Surgeon General’s report - how tobacco smoke causes disease: thiology and behavioraasis for smoking-attributablisease. Washington, (DC): Centers for Disease Control and Prevention; 2010.
94. Varlet V, Farsalinos K, Augsburge, et al. Toxicity assessment of refill liquids folectronic cigarettes. Int J Environ Res Public Health. 2015;12:4796-815.
95. Vitrocell. VC10 Smoking Robot. Available from: http://www.vitrocell.com/inhalation-toxicology/smoking-machines/vc-10 [last accessed 1 June 2016].
96. West R, Hajek P, Mcneill A, et al. 2015. http://www.smokinginengland.info/reports/
97. World Health Organization. 2008. http://apps.who.int/iris/bitstream/10665/43997/1/TRS951_eng.pdf?ua=1
98. Williams M, Villarreal A, Bozhilov K, et al. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013;8:e57987.
99. Yu V, Rahimy M, Korrapati A, et al. Electronic cigarettes induce DNA strand breaks and celeath independently of nicotine in cell lines. Oral Oncol. 2016;52:58-65.